We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cynapsus Therapeutics Provides Research Update for Parkinson's Drug Candidate

Product News   Jun 27, 2011

 
Cynapsus Therapeutics Provides Research Update for Parkinson's Drug Candidate
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Phase 1 Clinical Trial of COVID-19 Vaccine UB-612 Initiates in Taiwan

Product News

The first volunteers have been safely dosed in COVAXX's Phase 1, open-label, dose-escalation study of the UB-612 vaccine candidate for COVID-19 in Taiwan.

READ MORE

Phase III Trial of Janssen's COVID-19 Vaccine Launched

Product News

Johnson & Johnson today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate, JNJ-78436735, being developed by its Janssen Pharmaceutical Companies.

READ MORE

Univercells Technologies introduces the NevoLine™ Upstream Platform

Product News

This upstream manufacturing platform is suitable for multiple viral applications to support the booming gene therapy market and offer a cost-effective tool for rapid response to emerging infectious diseases.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE